Compulsory licensing for expensive medicines

Research output: Book/ReportReportpeer-review

  • Esther Van Zimmeren
  • Minssen, Timo
  • Liesbet Paemen
  • Walter Van Dyck
  • Jeroen Luyten
  • Rosanne Janssens
  • Liese Barbier
  • Steven Simoens
  • Celine Pouppez (Editor)
  • Irina Cleemput (Editor)
  • Imgard Vinck (Editor)
Van Zimmeren E, Minssen T, Paemen L, Van Dyck W, Luyten J, Janssens R, Barbier L, Simoens S, Pouppez C, Cleemput I, Vinck I. Compulsory licensing for expensive medicines. Health Services Research (HSR) Brussels: Belgian Health Care Knowledge Centre (KCE). 2022. KCE Reports 356. D/2022/10.273/35. This document is available on the website of the Belgian Health Care Knowledge Centre.
Original languageEnglish
Place of PublicationBrussels
PublisherBelgian Health Care Knowledge Centre (KCE).
Number of pages200
Publication statusPublished - 14 Jun 2022

    Research areas

  • Faculty of Law - Patents, Data, compulsory licensing, expensive medicine

ID: 310249981